Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Mid Cap Fund |
|---|---|
| 28 Nov 2016 | ₹100.00 |
| 20 Sep 2017 | ₹132.09 |
| 13 Jul 2018 | ₹138.11 |
| 05 May 2019 | ₹131.26 |
| 25 Feb 2020 | ₹147.55 |
| 17 Dec 2020 | ₹175.44 |
| 09 Oct 2021 | ₹270.69 |
| 01 Aug 2022 | ₹269.04 |
| 24 May 2023 | ₹294.57 |
| 15 Mar 2024 | ₹404.23 |
| 05 Jan 2025 | ₹561.45 |
| 28 Oct 2025 | ₹575.21 |
| 20 Aug 2026 | ₹621.48 |
| Metric | Edelweiss · Direct NAV ₹130.88 Very High risk ★★★★★ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +9.90% | +9.87% | |
| +23.90% | +19.74% | |
| +20.76% | +17.84% | |
| — | +17.01% | |
| +20.67% | +19.29% | |
| +20.94% | — | |
| +22.79% | +20.53% | |
| +23.68% | +19.07% | |
| — | +18.49% | |
| Risk | ||
| 16.64% | 16.20% | |
| 1.05 | 0.83 | |
| 1.43 | 1.14 | |
| -39.21% | -32.95% | |
| Nifty Midcap 150 | — | |
| +5.30% | +2.33% | |
| 0.95 | 0.94 | |
| 106.7% | 98.4% | |
| 84.4% | 87.8% | |
| 0.72% | 0.97% | |
| ₹16,310Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 40% | 40% | |
| Trideep Bhattacharya · 4.9y | — | |
| 28 Nov 2016 | — | |
| 92 | — | |
| 22.4% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.